| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.0086 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |